For: | Niu ZS, Wang WH, Niu XJ. Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World J Gastroenterol 2022; 28(46): 6433-6477 [PMID: 36569275 DOI: 10.3748/wjg.v28.i46.6433] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i46/6433.htm |
Number | Citing Articles |
1 |
E.L. Bueverova, O.Yu. Zolnikova, M.A. Paltzev. Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints. Molekulyarnaya Meditsina (Molecular medicine) 2024; 22(1): 3 doi: 10.29296/24999490-2024-01-01
|
2 |
Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou. Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory Markers. Cancer Control 2024; 31 doi: 10.1177/10732748241236333
|
3 |
Yifei Zhu, Jiayi Gu, Yuxin Lu, Qianying Tao, Xinliang Cao, Yanqing Zhu, Mu-qing Yang, Xin Liang. IL-6 Released from Hepatic Stellate Cells Promotes Glycolysis and Migration of HCC Through the JAK1/vWF/TGFB1 Axis. Journal of Hepatocellular Carcinoma 2024; : 1295 doi: 10.2147/JHC.S464880
|
4 |
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, Ning Wang, Yibin Feng. The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma. Medicinal Research Reviews 2023; 43(6): 1946 doi: 10.1002/med.21967
|
5 |
Qiankun Yang, Lanlan Dong, Lianglu Zhang, Wei Zhang, Yan Zhang, Yue Huang, Huifang Jin, Hao Yang, Xing Liu, Yanteng Zhao. Analytical and Diagnostic Performance of a Dual‐Target Blood Detection Test for Hepatocellular Carcinoma. Cancer Reports 2024; 7(9) doi: 10.1002/cnr2.70017
|
6 |
Xue Ren, Ying Zhao, Nan Wang, Jiahui Liu, Shuo Zhang, Mingrui Zhuang, Hongkai Wang, Jixiang Wang, Yindi Zhang, Qingwei Song, Ailian Liu. Intravoxel incoherent motion and enhanced T2*-weighted angiography for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1389769
|
7 |
Xiaqing Gao, Chunting Yang, Hailong Li, Lihua Shao, Meng Wang, Rong Su. EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47886-z
|
8 |
Yu-Bo Zhang, Gang Yang, Yang Bu, Peng Lei, Wei Zhang, Dan-Yang Zhang. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(43): 5804-5817 doi: 10.3748/wjg.v29.i43.5804
Abstract(335) |
Core Tip(352) |
Full Article(HTML)(1563)
|
Full Article with Cover (PDF)-11693K(74)
|
Full Article (Word)-2351K(25)
|
Audio-1157K(7)
|
Peer-Review Report-278K(36)
|
Answering Reviewers-84K(35)
|
Full Article (PDF)-6029K(122)
|
Full Article (XML)-120K(39)
|
Times Cited (6)
|
Total Visits (4788)
|
Open
|
9 |
Yubei He, Han Xu, Yu Liu, Stefan Kempa, Carolina Vechiatto, Robin Schmidt, Emine Yaren Yilmaz, Luisa Heidemann, Jörg Schnorr, Susanne Metzkow, Eyk Schellenberger, Akvile Häckel, Andreas Patzak, Dominik N. Müller, Lynn Jeanette Savic. The Effects of Hypoxia on the Immune–Metabolic Interplay in Liver Cancer. Biomolecules 2024; 14(8): 1024 doi: 10.3390/biom14081024
|
10 |
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, Nikolaos Machairas. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?. Cancers 2023; 15(12): 3161 doi: 10.3390/cancers15123161
|